Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection

Iranian Journal of Immunology

Volumn 4, Issue 2, 2007, Pages 94-100

  Rafatpanah, Houshang ^a,b,e   Pravica, Vera ^b   FaridHosseini, Reza ^a   Tabatabaei, Abbas ^c   Ollier, Wiliam ^b   Poulton, Kay ^d   Thomson, Wendy ^b   Hutchinson, Ian ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Trafford Healthcare Trust   (United Kingdom)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HAM TSP; HLA; HTLV I

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA C ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; GENE FREQUENCY; HLA SYSTEM; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IRAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE;

EID: 34250822869     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985; 2:407-10.
2. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI et al. Adult T-cell leukaemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981;78:6476-80.
3. Safai B, Huang JL, Boeri E, Farid R, Raafat J, Schutzer P et al. Prevalence of HTLV type I infection in Iran: a serological and genetic study. AIDS Res Hum Retroviruses. 1996; 12:1185-90.
4. Abbaszadegan MR, Gholamin M, Tabatabaee A, Farid R, Houshmand M, Abbaszadegan M. Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran. J Clin Microbiol. 2003; 41:2593-5.
5. Hill AV. The immunogenetics of human infectious diseases. Annu Rev Immunol. 1998; 16:593-617.
6. Aebischer T, Moskophidis D, Rohrer UH, Zinkernagel RM, Hengartner H. In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A.1991;88:11047-51.
7. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 1993; 364:33-9.
8. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987;329:512-8.
9. Kannagi M, Shida H, Igarashi H, Kuruma K, Murai H, Aono Y et al. Target epitope in the Tax protein of human T-cell leukaemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol 1992; 66:2928-33.
10. Koenig S, Woods RM, Brewah YA, Newell AJ, Jones GM, Boone E et al. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol.1993; 151:3874-83.
11. Daenke S, Kermode AG, Hall SE, Taylor G, Weber J, Nightingale S, Bangham CR. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. Virology. 1996; 217:139-46.
12. Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A.1999;96:3848-53.
13. Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol. 2000; 165:7278-84.
14. Sabouri AH, Saito M, Usuku K, Bajestan SN, Mahmoudi M, Forughipour M et al. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J Gen Virol. 2005; 86:773-81.
15. World Health Organization. Report of the scientific group on HTLV-I and associated diseases, Kagoshima, Japan, December 1988: Virus Disease. WHO Wkly Epidemiol Rec. 1989;49:382-3.
16. Rafatpanah H, Pravica V, Farid R, Abbaszadegan MR, Tabatabaei A, Goharjoo A et al. Association of a novel single nucleotide polymorphism in the human perforin gene with the outcome of HTLV-I infection in patients from northeast Iran (Mashhad). Hum Immunol. 2004; 65:839-46.
17. Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence- specific primers (PCR-SSP). Tissue Antigens. 1995; 46:355-67.
18. Abbas AK, Lichtman AH, Pober JS. Effector mechanisms of T cell-mediated immune reactions. In: cellualar and Molexcualr Immunology. 3nd ed. Philadelphia: W.B. Saunders Company; 1997.p.228-96.
19. Kannagi M, Shida H, Igarashi H, Kuruma K, Murai H, Aono Y et al. Target epitope in the Tax protein of human T-cell leukaemia virus type I recognised by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol. 1992; 66; 2928-33.
20. Koenig S, Woods RM, Brewah YA, Newell AJ, Jones GM, Boone E et al. Characterisation of MHC class I restricted cytotoxic T cell response to tax in HTLV-1 infected patients with neurologic disease. J immunol.1993; 151:3874-83.
21. Sonoda S, Fujiyoshi T, Yashiki S. Immunogenetics of HTLV-I/II and associated diseases. J Acquir Immune Defic Syndr Hum Retrovirol.1996; 13: 119-23.
22. Nishimura M, Maeda M, Matsuoka M, Mine H, Saji H, Matsui M et al. Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy. Hum Immunol. 2000;61:1262-9.
23. Amirzargar A, Mytilineos J, Farjadian S, Doroudchi M, Scherer S, Opelz G et al. Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population. Hum Immunol. 2001; 62:1234-8.
24. Manns A, Hanchard B, Morgan OS, Wilks R, Cranston B, Nam JM et al. Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult T-cell leukaemia/lymphoma in a Black population. J Natl Cancer Inst. 1998; 90:617-22.
25. Ijichi S, Izumo S, Eiraku N, Machigashira K, Kubota R, Nagai M et al. An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP. Med Hypotheses.1993; 41:542-7.
26. Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y et al. Abundant tax protein expression in CD4+ T cells infected with human T- cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood. 2000;95:1386-92.
27. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature.1994; 368:215-21.
28. Yashiki S, Fujiyoshi T, Arima N, Osame M, Yoshinaga M, Nagata Y et al. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukaemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes. AIDS Res Hum Retroviruses. 2001;17:1047-61.
29. Hollsberg P. Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev. 1999;63:308-33.
30. Sipsas NV, Kalams SA, Trocha A, He S, Blattner WA, Walker BD et al. Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. J Clin Invest. 1997;99:752-62.
31. Castelli C, Tarsini P, Mazzocchi A, Rini F, Rivoltini L, Ravagnani F et al. Novel HLA-Cw*08-restricted T cell epitopes derived from tyrosinase- related protein-2 and gp100 melanoma antigens. J Immunol. 1999;162:1739-48.